Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam
- 13 December 2013
- journal article
- Published by Taylor & Francis Ltd in Drug Delivery
- Vol. 22 (4), 487-498
- https://doi.org/10.3109/10717544.2014.885615
Abstract
The present work was performed aiming to develop a new solid self-emulsifying system (SMEDDS) for poorly water-soluble drug Lornoxicam and evaluate the bioavailability in Wister rats by oral gavage. Liquid SMEDDS of Lornoxicam was formulated with Labrafil M 1944 CS as oil phase, Kolliphor HS 15 as a surfactant and Transcutol HP as a cosurfactant after screening various vehicles. The microemulsion system selected from the phase diagram and optimized by central composite design (CCD) response surface method was transformed into solid-SMEDDS (S-SMEDDS) by lyophilization using sucrose as cryoprotectant. The formulations were further characterized by the particle size, poly dispersity index (PDI), self-emulsifying time, zeta potential, transmission electron microscope (TEM), differential scanning calorimeter (DSC), in vitro drug release and in vivo pharmacokinetics. Results of DSC studies confirmed that the drug was incorporated in the S-SMEDDS. The in vitro drug release from Lornoxicam SMEDDS was found to be greatly higher in comparison with that from the commercial tablets. It was indicated that SMEDDS might be effective in reducing the effect of pH variability of Lornoxicam and improving the release performance of Lornoxicam. HPLC system was applied to study the concentration of Lornoxicam in the plasma of the Wister rats after oral administration of Lornoxicam SMEDDS and Lornoxicam commercial tablets. The pharmacokinetics parameters of the rats were Cmax 1065.91 ± 224.90 and 1855.22 ± 748.25 ngmL−1, Tmax were 2.5 ± 0.4 h and 1.8 ± 0.5 h, and AUC0∼t were 5316.35 ± 323.62 and 7758.07 ± 241.57 ngmL−1 h, respectively. Calculated by AUC0∼∞, the relative bioavailability of Lornoxicam S-SMEDDS was 151.69 ± 15.32%. It suggested that this S-SMEDDS could be used as a successful oral solid dosage form to improve the solubility and bioavailability of poorly water-soluble drug Lornoxicam as well.Keywords
This publication has 21 references indexed in Scilit:
- Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailabilityActa Pharmaceutica Sinica. B, 2012
- Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimizationInternational Journal of Pharmaceutics, 2009
- Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile saltInternational Journal of Pharmaceutics, 2009
- Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systemsInternational Journal of Pharmaceutics, 2009
- Preparation and Evaluation of Self-Microemulsifying Drug Delivery System Containing VinpocetineDrug Development and Industrial Pharmacy, 2009
- The use of solid self-emulsifying systems in the delivery of diclofenacInternational Journal of Pharmaceutics, 2003
- Improving drug solubility for oral delivery using solid dispersionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge.Pharmaceutical Research, 1998
- Factors Affecting the Efficiency of a Self-Emulsifying Oral Delivery SystemDrug Development and Industrial Pharmacy, 1997
- Effect of the inhibitors of different steps of cholesterol biosynthesis pathway on high density lipoprotein binding to isolated human enterocytesInternational Journal of Pharmaceutics, 1993